Hand Osteoarthritis Clinical Trial
Official title:
Self-care Program Evaluation With Focus on Assistive Devices for Individuals With Hand Osteoarthritis
Verified date | January 2016 |
Source | Universidade Federal de Pernambuco |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Randomized clinical trial , blind for evaluators, to assess the effectiveness of a self-care program using assistive technology for treatment of hand osteoarthritis.
Status | Completed |
Enrollment | 39 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Hand OA diagnosis according to the criteria of the American College of Rheumatology (ACR ) - Be properly registered in the rheumatology clinic of Hospital das ClĂnicas Exclusion Criteria: - Surgical treatment or infiltration in the hands, in the last 6 months; - Treatment of occupational therapy and / or physical therapy, or use of any TA feature (assist device or stent) in the last 6 months; - Diagnosis of another rheumatologic disease or musculoskeletal system that compromise the hands associated. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital das Clínicas - Universidade Federal de Pernambuco | Recife | PE |
Lead Sponsor | Collaborator |
---|---|
Daniela Salgado Amaral |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Occupational Performance | involvement of daily activities by the Canadian Occupational Performance Measure (COPM) | 4 weeks | No |
Secondary | Quality of life | Evaluation by WHO-QOL bref | 4 weeks | No |
Secondary | Manual functional | Evoluation by SACRAH | 4 weeks | No |
Secondary | Pain | Evaluation by visual analogue pain scale | 4 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02612233 -
Pain Management in Osteoarthritis Using the Centrally Acting Analgesics Duloxetine and Pregabalin
|
Phase 4 | |
Completed |
NCT01910116 -
Efficacy of Shinabro in Hand Osteoarthritis
|
Phase 2/Phase 3 | |
Completed |
NCT01249391 -
Splinting to Treat Hand Osteoarthritis
|
Phase 2 | |
Recruiting |
NCT04402047 -
Electroacupuncture vs Topical Diclofenac Sodium Gel for Patients With Hand Osteoarthritis
|
N/A | |
Completed |
NCT03911570 -
Crystalline Glucosamine Sulfate Therapy in Hand Osteoarthritis
|
||
Completed |
NCT04576403 -
Heated Mittens for Patients With Hand Osteoarthritis
|
N/A | |
Completed |
NCT01874067 -
C-GLOVES: the Effectiveness of Compression Gloves in Arthritis
|
||
Completed |
NCT02528630 -
Progressive Strength in Hand Osteoarthritis
|
Phase 4 | |
Suspended |
NCT03703934 -
Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls
|
||
Completed |
NCT04585113 -
Diagnostic Accuracy of Dual-energy CT
|
||
Completed |
NCT05568875 -
Happy Hands - an E-self-management Intervention for People With Hand Osteoarthritis
|
N/A | |
Completed |
NCT03693833 -
CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
|
Phase 2 | |
Completed |
NCT05150171 -
Happy Hands E-self-management Pilot Study
|
N/A | |
Completed |
NCT02477059 -
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
|
Phase 3 | |
Recruiting |
NCT04611347 -
Topical CBD in Joint Arthritis
|
Phase 2 | |
Completed |
NCT04036929 -
Can we Use Estrogen-containing Therapy to Improve Pain in Women After Menopause With Hand Osteoarthritis?
|
N/A | |
Completed |
NCT03919279 -
Treatment of Erosive Digital Osteoarthritis by Transcutaneous Auricular Nerve Stimulation
|
N/A | |
Recruiting |
NCT06329219 -
Water-filtered Infrared-A Radiation in Patients With Hand Osteoarthritis
|
N/A | |
Not yet recruiting |
NCT05216757 -
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
|
Phase 2/Phase 3 | |
Completed |
NCT02771860 -
RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints
|
Phase 2 |